Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Jun;82(11):1887–1891. doi: 10.1054/bjoc.1999.1243

Mortality from cutaneous melanoma: evidence for contrasting trends between populations

G Severi 1, G G Giles 2, C Robertson 1, P Boyle 1, P Autier 1
PMCID: PMC2363233  PMID: 10839308

Abstract

In recent years several reports have been published concerning trends in melanoma mortality in different countries, some of which have indicated that rates are beginning to fall. Many of these reports, however, have been based on small populations and have used different forms of statistical analysis. Our objective was to analyse systematically to what degree the epidemic of melanoma mortality had evolved similarly in different populations and whether there were any divergent trends that might increase our understanding. Instead of using all available data, we focused on countries with a minimum time series of 30 years and a minimum of 100 deaths annually in at least one sex from melanoma. We first inspected sex-specific age-standardized mortality rates and then performed age-period-cohort modelling. We found that the increase in mortality observed after 1950 was more pronounced in the age group 60–79. Statistical modelling showed a general increase in mortality rates in generations born after the turn of the century. Downturns in mortality, essentially in women and starting with generations born just before World War II, were found in Australia (where the earliest decreases were noted), the Nordic countries and the USA. Small decreases in rates in more recent generations were found in the UK and Canada. However, in France, Italy and Czechoslovakia, mortality rates were seen to be still increasing in recent cohorts. Our analysis suggests that populations are at different places on the melanoma mortality epidemic curve. The three trend patterns we observed are in agreement with time differences between populations with respect to the promotion of sun protection and the surveillance of pigmented skin lesions. © 2000 Cancer Research Campaign

Keywords: melanoma, mortality, trends, prevention programmes, sun exposure

Full Text

The Full Text of this article is available as a PDF (70.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong B. K., Kricker A. Cutaneous melanoma. Cancer Surv. 1994;19-20:219–240. [PubMed] [Google Scholar]
  2. Autier P., Doré J. F. Influence of sun exposures during childhood and during adulthood on melanoma risk. EPIMEL and EORTC Melanoma Cooperative Group. European Organisation for Research and Treatment of Cancer. Int J Cancer. 1998 Aug 12;77(4):533–537. doi: 10.1002/(sici)1097-0215(19980812)77:4<533::aid-ijc10>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  3. Balzi D., Carli P., Geddes M. Malignant melanoma in Europe: changes in mortality rates (1970-90) in European Community countries. Cancer Causes Control. 1997 Jan;8(1):85–92. doi: 10.1023/a:1018491323442. [DOI] [PubMed] [Google Scholar]
  4. Bleyen L., De Bacquer D., Myny K., Brochez L., Naeyaert J. M., De Backer G. Trends in mortality from cutaneous malignant melanoma in Belgium. Int J Epidemiol. 1999 Feb;28(1):40–45. doi: 10.1093/ije/28.1.40. [DOI] [PubMed] [Google Scholar]
  5. Bucchi L., Serafini M., Lanzanova G. Breslow thickness of cutaneous malignant melanoma in Ravenna (northern Italy) 1981-1990. Tumori. 1992 Apr 30;78(2):94–97. doi: 10.1177/030089169207800206. [DOI] [PubMed] [Google Scholar]
  6. Burton R. C., Armstrong B. K. Recent incidence trends imply a nonmetastasizing form of invasive melanoma. Melanoma Res. 1994 Apr;4(2):107–113. doi: 10.1097/00008390-199404000-00005. [DOI] [PubMed] [Google Scholar]
  7. English D. R., Milne E. Favorable trends in melanoma incidence: can we claim credit? Cancer Causes Control. 1999 Oct;10(5):403–405. doi: 10.1023/a:1008985019082. [DOI] [PubMed] [Google Scholar]
  8. Giles G. G., Armstrong B. K., Burton R. C., Staples M. P., Thursfield V. J. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. BMJ. 1996 May 4;312(7039):1121–1125. doi: 10.1136/bmj.312.7039.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Holford T. R. Analysing the temporal effects of age, period and cohort. Stat Methods Med Res. 1992;1(3):317–337. doi: 10.1177/096228029200100306. [DOI] [PubMed] [Google Scholar]
  10. Holford T. R. The estimation of age, period and cohort effects for vital rates. Biometrics. 1983 Jun;39(2):311–324. [PubMed] [Google Scholar]
  11. La Vecchia C., Lucchini F., Negri E., Levi F. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer. 1999 Mar 31;81(1):62–66. doi: 10.1002/(sici)1097-0215(19990331)81:1<62::aid-ijc12>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  12. Lee J. A., Petersen G. R., Stevens R. G., Vesanen K. The influence of age, year of birth, and date on mortality from malignant melanoma in the populations of England and Wales, Canada, and the white population of the United States. Am J Epidemiol. 1979 Dec;110(6):734–739. doi: 10.1093/oxfordjournals.aje.a112854. [DOI] [PubMed] [Google Scholar]
  13. MacKie R. M., Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. BMJ. 1992 Apr 18;304(6833):1012–1015. doi: 10.1136/bmj.304.6833.1012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. MacKie R. M., Hole D., Hunter J. A., Rankin R., Evans A., McLaren K., Fallowfield M., Hutcheon A., Morris A. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group. BMJ. 1997 Nov 1;315(7116):1117–1121. doi: 10.1136/bmj.315.7116.1117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. MacKie R., Hunter J. A., Aitchison T. C., Hole D., Mclaren K., Rankin R., Blessing K., Evans A. T., Hutcheon A. W., Jones D. H. Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet. 1992 Apr 18;339(8799):971–975. doi: 10.1016/0140-6736(92)91539-k. [DOI] [PubMed] [Google Scholar]
  16. Melia J. Early detection of cutaneous malignant melanoma in Britain. Int J Epidemiol. 1995;24 (Suppl 1):S39–S44. doi: 10.1093/ije/24.supplement_1.s39. [DOI] [PubMed] [Google Scholar]
  17. Måsbäck A., Westerdahl J., Ingvar C., Olsson H., Jonsson N. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review. Cancer. 1994 Mar 15;73(6):1625–1630. doi: 10.1002/1097-0142(19940315)73:6<1625::aid-cncr2820730614>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  18. Rivers J. K., Gallagher R. P. Public education projects in skin cancer. Experience of the Canadian Dermatology Association. Cancer. 1995 Jan 15;75(2 Suppl):661–666. doi: 10.1002/1097-0142(19950115)75:2+<661::aid-cncr2820751408>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  19. Robinson J. K., Rigel D. S., Amonette R. A. Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996. J Am Acad Dermatol. 1997 Aug;37(2 Pt 1):179–186. doi: 10.1016/s0190-9622(97)80122-3. [DOI] [PubMed] [Google Scholar]
  20. Roush G. C., McKay L., Holford T. R. A reversal in the long-term increase in deaths attributable to malignant melanoma. Cancer. 1992 Apr 1;69(7):1714–1720. doi: 10.1002/1097-0142(19920401)69:7<1714::aid-cncr2820690712>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  21. Scotto J., Pitcher H., Lee J. A. Indications of future decreasing trends in skin-melanoma mortality among whites in the United States. Int J Cancer. 1991 Oct 21;49(4):490–497. doi: 10.1002/ijc.2910490403. [DOI] [PubMed] [Google Scholar]
  22. Swerdlow A. J. International trends in cutaneous melanoma. Ann N Y Acad Sci. 1990;609:235–251. doi: 10.1111/j.1749-6632.1990.tb32071.x. [DOI] [PubMed] [Google Scholar]
  23. Thörn M., Pontén F., Bergström R., Sparén P., Adami H. O. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst. 1994 May 18;86(10):761–769. doi: 10.1093/jnci/86.10.761. [DOI] [PubMed] [Google Scholar]
  24. Venzon D. J., Moolgavkar S. H. Cohort analysis of malignant melanoma in five countries. Am J Epidemiol. 1984 Jan;119(1):62–70. doi: 10.1093/oxfordjournals.aje.a113726. [DOI] [PubMed] [Google Scholar]
  25. van der Spek-Keijser L. M., van der Rhee H. J., Tóth G., Van Westering R., Bruijn J. A., Coebergh J. W. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980. Br J Dermatol. 1997 Apr;136(4):565–571. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES